Literature DB >> 11283254

Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.

T Buschmann1, O Potapova, A Bar-Shira, V N Ivanov, S Y Fuchs, S Henderson, V A Fried, T Minamoto, D Alarcon-Vargas, M R Pincus, W A Gaarde, N J Holbrook, Y Shiloh, Z Ronai.   

Abstract

The p53 tumor suppressor protein plays a key role in the regulation of stress-mediated growth arrest and apoptosis. Stress-induced phosphorylation of p53 tightly regulates its stability and transcriptional activities. Mass spectrometry analysis of p53 phosphorylated in 293T cells by active Jun NH2-terminal kinase (JNK) identified T81 as the JNK phosphorylation site. JNK phosphorylated p53 at T81 in response to DNA damage and stress-inducing agents, as determined by phospho-specific antibodies to T81. Unlike wild-type p53, in response to JNK stimuli p53 mutated on T81 (T81A) did not exhibit increased expression or concomitant activation of transcriptional activity, growth inhibition, and apoptosis. Forced expression of MKP5, a JNK phosphatase, in JNK kinase-expressing cells decreased T81 phosphorylation while reducing p53 transcriptional activity and p53-mediated apoptosis. Similarly transfection of antisense JNK 1 and -2 decreased T81 phosphorylation in response to UV irradiation. More than 180 human tumors have been reported to contain p53 with mutations within the region that encompasses T81 and the JNK binding site (amino acids 81 to 116). Our studies identify an additional mechanism for the regulation of p53 stability and functional activities in response to stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283254      PMCID: PMC86905          DOI: 10.1128/MCB.21.8.2743-2754.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms.

Authors:  Y Haupt; S Rowan; E Shaulian; A Kazaz; K Vousden; M Oren
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

2.  Regulation of mutant p53 temperature-sensitive DNA binding.

Authors:  P Friedlander; Y Legros; T Soussi; C Prives
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

3.  Identification of a novel p53 functional domain that is necessary for efficient growth suppression.

Authors:  K K Walker; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase.

Authors:  S Y Fuchs; L Dolan; R J Davis; Z Ronai
Journal:  Oncogene       Date:  1996-10-03       Impact factor: 9.867

6.  Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53.

Authors:  R B Tishler; D M Lamppu; S Park; B D Price
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

7.  Conformation-dependent phosphorylation of p53.

Authors:  V Adler; M R Pincus; T Minamoto; S Y Fuchs; M J Bluth; P W Brandt-Rauf; F K Friedman; R C Robinson; J M Chen; X W Wang; C C Harris; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

8.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

10.  Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression.

Authors:  T Unger; J A Mietz; M Scheffner; C L Yee; P M Howley
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more
  70 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

3.  Nuclear β-adrenergic receptors modulate gene expression in adult rat heart.

Authors:  George Vaniotis; Danny Del Duca; Phan Trieu; Charles V Rohlicek; Terence E Hébert; Bruce G Allen
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

4.  Ultraviolet irradiation-induced K(+) channel activity involving p53 activation in corneal epithelial cells.

Authors:  Ling Wang; Wei Dai; Luo Lu
Journal:  Oncogene       Date:  2005-04-21       Impact factor: 9.867

Review 5.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

6.  Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.

Authors:  Cristina Cellurale; Guadalupe Sabio; Norman J Kennedy; Madhumita Das; Marissa Barlow; Peter Sandy; Tyler Jacks; Roger J Davis
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

7.  Control of p53 multimerization by Ubc13 is JNK-regulated.

Authors:  Ivan Topisirovic; Gustavo J Gutierrez; Meifan Chen; Ettore Appella; Katherine L B Borden; Ze'ev A Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

8.  Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.

Authors:  Olivia I Koues; R Kyle Dudley; Agnieszka D Truax; Dawson Gerhardt; Kavita P Bhat; Sam McNeal; Susanna F Greer
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

9.  The prolyl isomerase Pin1 is overexpressed in human esophageal cancer.

Authors:  Huawei Jin; Jie Jiang; Lifang Sun; Fangfang Zheng; Chengyan Wu; Lin Peng; Yufen Zhao; Xueji Wu
Journal:  Oncol Lett       Date:  2011-08-23       Impact factor: 2.967

10.  Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.

Authors:  Ji-Young Jang; Yoon-Kyung Jeon; Yun Choi; Chul-Woo Kim
Journal:  Mol Cancer       Date:  2010-09-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.